Smoldering multiple myeloma. [N Engl J Med. 2007] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: N Engl J Med. 2007 Sep 6;357(10):1048; author reply 1049-50.Links

Comment on:: N Engl J Med. 2007 Jun 21;356(25):2582-90.

Smoldering multiple myeloma.

Prasad HK, Zhan F, Shaughnessy J.

PMID: 17804853 [PubMed - indexed for MEDLINE]

Related articles

Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profiling.
Clin Cancer Res. 2007 Dec 1; 13(23):7073-9.

[Clin Cancer Res. 2007]
IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma.
Leukemia. 2006 Jan; 20(1):174-6.

[Leukemia. 2006]
ReviewGenetic events in the pathogenesis of multiple myeloma.
Best Pract Res Clin Haematol. 2007 Dec; 20(4):571-96.

[Best Pract Res Clin Haematol. 2007]
Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myélome.
J Clin Oncol. 2008 Oct 10; 26(29):4798-805. Epub 2008 Jun 30.

[J Clin Oncol. 2008]
ReviewInput of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications.
Clin Cancer Res. 2007 Dec 15; 13(24):7289-95.

[Clin Cancer Res. 2007]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Smoldering multiple myeloma.Smoldering multiple myeloma.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show